1 of 2 companies that have FDA approval for Anti-radiation pill

nukepills.com
MEDPOINTE INC

purchased by the Carlyle group --who will benefit
from a nuclear holocaust



On September 28, 2001, Carter-Wallace was acquired by a group of investors led The Carlyle Group and The Cypress Group, following a vote by Carter-Wallace shareholders approving the transaction. The company, which has been renamed MedPointe, is now privately owned. Investors include:
The Carlyle Group is a global diversified private equity firm that originates, structures and acts as an equity investor in management buyouts, corporate partnerships, platform consolidations, private placements and growth investments. Carlyle currently manages approximately $17.5 billion of capital across 23 institutional funds, including a $3.9 billion domestic leveraged buyout fund. Carlyle has completed well over 300 transactions, investing over $10.4 billion of equity and purchasing more than $20.0 billion of assets. View Web site

The Cypress Group is a private equity investment fund whose objective is to achieve long-term capital appreciation through growth-oriented, privately negotiated equity investment. Cypress currently manages over $3.5 billion of equity capital on behalf of major pension funds, university endowments and other leading financial institutions. As principals, Cypress professionals have invested a total of approximately $4.1 billion in businesses with an aggregate transaction value of approximately $21 billion. View Web site

Ferrer Freeman & Company, LLC ("FFC") is a private equity firm with more than $500 million under management that invests exclusively in healthcare and healthcare-related companies. Its two institutional funds include well-respected corporate and public pension funds; financial institutions; and university, charitable and family endowments. FFC invests in growing private companies, in leveraged buyouts and in privately negotiated transactions in publicly held companies. As of September 2003, FFC has invested funds in 22 portfolio companies in the provider, managed care, healthcare IT, device, workflow solutions and pharmaceutical sectors of the healthcare industry. View Web site

Frazier Healthcare Ventures, with over $750 million under management, is one of the nation's premiere providers of early stage venture capital and growth equity to biotech, medical device and other healthcare companies. Established in 1991, Frazier Healthcare has invested in more than 60 emerging healthcare companies and has amassed one of the largest and most experienced private-equity healthcare investment teams within the venture community. Frazier Healthcare's investment members include seasoned clinical, scientific, operational and financial professionals who collaborate with entrepreneurs every step of the way. View Web site

 

en.wikipedia.org/wiki/Carlyle_Group